Skip to content

End-of-life distress: all studies

Page 10 of 40: studies 91 to 100 of 391, newest first. Back to the end-of-life distress overview

Research

Using guided imagery and hypnosis in brief therapy and palliative care

American Journal of Clinical Hypnosis February 24, 2022 Donald Moss

About the Author: Rubin Battino (1931-present) is well known to many in Ericksonian circles for his engaging and practical books on psychotherapy, hypnosis, and guiding people to live more fully. Battino is both a professor emeritus in chemistry and a licensed professional counselor, specializing in brief therapy, an Ericksonian approach, and palliative care. His previous books include:...

The therapeutic potential of psychedelic substances in Hospice and Palliative Care

Progress in Palliative Care January 2, 2022 A. C. Garcia, L. O. Maia

The healthcare field and society at large are witnessing a resurgence of interest in the effects and applications of psychedelic therapies in a wide range of settings. In the 1950s and 1960s, research was conducted to explore different applications for psychedelics, such as lysergic acid diethylamide (LSD) and mescaline, in the healthcare setting. However, psychedelic research was dramatically...

Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review.

Psychopharmacology 2022 Nina Schimmers, Joost J. Breeksema, Sanne Y Smith-Apeldoorn et al.

Terminally ill patients may experience existential distress, depression, or anxiety, limiting quality of life in the final stage. Existing psychotherapeutic or pharmacological interventions have (time) limited efficacy. Psychedelic treatment may be a safe and effective alternative treatment option. Systematically review studies on psychedelic treatment with and without psychotherapy for...

The Potential of Psychedelics for End of Life and Palliative Care.

Current Topics in Behavioral Neurosciences 2022 David B. Yaden, Sandeep M. Nayak, Natalie Gukasyan et al. 31 citations

End of life and palliative care has improved in recent decades but the psychopharmacological options available to clinicians and patients in these contexts remain limited. In particular, psychological factors such as depression, existential distress, and well-being remain challenging to address with current medications. Here, we review recent research on the use of psychedelics in clinical...

Palliative care provider attitudes toward existential distress and treatment with psychedelic-assisted therapies

BMC Palliative Care December 26, 2021 Halsey F Niles, Colleen Fogg, Ben Kelmendi et al.

Abstract Background Existential distress is a significant source of suffering for patients facing life-threatening illness. Psychedelic-Assisted Therapies (PAT) are novel treatments that have shown promise in treating existential distress, but openness to providing PAT may be limited by stigma surrounding psychedelics and the paucity of education regarding their medical use. How PAT might be...

DOI: 10.1186/s12904-021-00889-x (opens in new tab) Full text (opens in new tab) Demoralization Psychedelic-assisted therapy psilocybin Powerful future tool Severe spiritual distress +4

Buprenorphine Microdosing for the Pain and Palliative Care Clinician

Journal of Palliative Medicine December 20, 2021 Kyle Quirk, Maximillian H. Stevenson

Buprenorphine (BUP) can be a safe and effective alternative to traditional opioids for many patients with chronic pain. For patients on higher doses of opioids, rotation to BUP is complicated by the requirement of an opioid-free interval or withdrawal during the transition. Microdosing inductions, in which BUP is gradually titrated, while full agonist opioids are continued, are a viable...

Exploring the Use of Psilocybin Therapy for Existential Distress: A Qualitative Study of Palliative Care Provider Perceptions

Journal of Psychoactive Drugs July 16, 2021 Coryn E. Mayer, Virginia Lebaron, Kimberly Acquaviva 17 citations

There is a growing body of research suggesting that palliative care patients coping with existential distress may benefit from psilocybin. However, there is a large gap regarding the perceptions of palliative care providers who may provide education, counseling services, recommendations, and/or prescriptions for psilocybin if it is decriminalized, commercialized, and/or federally rescheduled...

DOI: 10.1080/02791072.2021.1916659 (opens in new tab) Psilocybin Palliative care Distress Existentialism +5

Palliative care: is it time for health professionals to talk openly about psychedelic therapy?

British Journal of General Practice June 24, 2021 Emma Presern 1 citation

I’ve always been drawn to specialties where medicine can be practised holistically. It’s one of the reasons I applied for GP training and am currently undertaking a diploma in lifestyle medicine. My last post as a second-year GP trainee was a 6-month placement in palliative medicine at a well-known inner London hospice. While on this rotation, I came across patients who suffered with ‘total...

DOI: 10.3399/bjgp21x716333 (opens in new tab) Full text (opens in new tab) Distress Palliative care Mental health Existentialism +5

Acute and Sustained Reductions in Loss of Meaning and Suicidal Ideation Following Psilocybin-Assisted Psychotherapy for Psychiatric and Existential Distress in Life-Threatening Cancer

ACS Pharmacology & Translational Science March 18, 2021 Stephen Ross, Gabrielle Agin-Liebes, Sharon L. Lo et al. 133 citations

People with advanced cancer are at heightened risk of desire for hastened death (DHD), suicidal ideation (SI), and completed suicide. Loss of Meaning (LoM), a component of demoralization, can be elevated by a cancer diagnosis and predicts DHD and SI in this population. We completed a randomized controlled trial in which psilocybin-assisted psychotherapy (PAP) produced rapid and sustained...

At the Intersection of Palliative Care, Psychedelic Medicine, and Healthcare Reform: A Call for a New Hospice and Palliative Care Movement

Journal of Palliative Care August 4, 2020 Ilan Bernstein

As palliative care providers, we are expected to expertly address psychological and spiritual distress among our patients. Left unchecked, existential suffering threatens to exacerbate symptom burden and limit therapeutic potential. Tending to the psychospiritual domains of a person’s experience is thus as fundamental to our roles as healers as is familiarity with equianalgesic charts and bowel...